Reaffirms commitment to environmentally and socially responsible practices in R&D, clinical trials, manufacturing, and supply chain management to ena...
New reforestation projects in Brazil, India, Vietnam, Ghana and Rwanda in addition to existing projects including in Australia and Indonesia AstraZeneca h...
Cleveland Diagnostics, Inc., a commercial-stage biotechnology company developing next-generation diagnostic tests for the early detection of cancers, has o...
Merger approved with large majority by the shareholders of both companies New governance structure implemented Ambition to create a global leader in ex...
“This expansion of our relationship with Illumina is a continuation of Illumina Ventures’ strategy to pursue earlier stage investing,” sa...
Deloitte is proud to announce the launch of "Illustrate Change," a project that seeks to build momentum around representation in medical illustrations and ...
QIAGEN N.V. announced a notice (reiterating its notice to holders dated January 9, 2019) to holders of the following: - 0.500% Senior Unsecure...
This three-year collaboration aims to validate genetic drug targets and progress therapeutic molecules into clinical development. The joint resea...
QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) welcomes the publication of a new systematic evaluation that underlines the unique benefits of the compa...
-Swiss American CDMO and BioNTX have partnered to host the inaugural Biotechnology and Healthcare Industry Alliance of North Texas (BHIANT) launch meeting ...
Electrophysiology is a critical part of neuroscience research, especially when attempting to elucidate the neural network. Monitoring the brain's field pot...
SomaLogic, Inc., a leader in proteomics technology, announced today their collaboration with Citogen, the Longwood Group’s customer services and supp...
The record date will be 5 p.m. Burlington, North Carolina time on Tuesday, June 20, 2023, and The distribution date will be 11:59 p.m. Burlington, North...
Agilent Technologies Inc. (NYSE: A) announced today a highly-anticipated, complete workflow solution for targeted per- and polyfluoroalkyl substances (PFAS...
© 2025 Biopharma Boardroom. All Rights Reserved.
